Apimeds Pharma shares soar on Inscobee settlement May 5, 2026 02:15PM
Apimeds halted on volatility May 5, 2026 02:08PM
Apimeds settles with Inscobee, clears path for merger and $100M financing May 5, 2026 02:07PM
Apimeds Pharmaceuticals alleges breach by Inscobee in hostile takeover bid Mar 24, 2026 08:30AM
Apimeds closes $100 million PIPE financing, activates 1,000 bitcoin Dec 10, 2025 09:59AM


Dec 1, 2025 09:36AM Apimeds (APUS) halted, news pending
Dec 1, 2025 09:25AM Apimeds merges with MindWave in biotech-digital asset deal
Aug 25, 2025 02:11PM Apimeds partners with University of Alabama for biotech program
Jul 15, 2025 05:34PM Apimeds adds two executives to leadership team
May 16, 2025 04:15PM D. Boral Capital Acted as Sole Bookrunner to Apimeds Pharmaceuticals US, Inc. (NYSE:APUS) in connection with its $13.5 Million Initial Public Offering
Nov 8, 2024 06:18AM Apimeds Pharmaceuticals US (APUS) Files for 3.33M Share IPO at $3-$4/sh